Antheia, Inc. is an advanced biotechnology research and biosynthesis company headquartered in Menlo Park, California, delivering 21st-century pharmaceutical solutions.
Subscribe to see Antheia, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Antheia, Inc. is a biotech company headquartered in United States. It has raised at least $146.4M across the 5 funding rounds on record. Its most recent funding round, Series C, raised $56M in June 2025. Xcout tracks 23 named people at Antheia, Inc., including Zack McGahey (Chief Operating Officer). Xcout recorded 12 job postings from Antheia, Inc. in the last 90 days.
17 more named people on record for Antheia, Inc., with roles, board committees and tenure — see the full roster →
At least $146.4M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $56M | 5 named | |
| — | $73M | 4 named | |
| SEC Form D filing | $9.2M | — | |
| SEC Form D filing | $6.2M | — | |
| SEC Form D filing | $2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 12 job postings from Antheia, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Antheia, Inc.'s hiring signals →
A few of Antheia, Inc.'s closest competitors — see the full list of competitors and alternatives →
Hexagon Bio, Inc. is a biotechnology company headquartered in Menlo Park, California, that is developing natural crop protections. The company focuses on utilizing its proprietary technology and pipeline to discover novel products.
Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Enveda Biosciences (Enveda Therapeutics Inc.) is a biotechnology research company headquartered in Boulder, Colorado. The company leverages artificial intelligence to discover novel therapeutics and chemical compounds derived from natural sources.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.